OBJECTIVES: To assess the prevalence of hypertension, elevated blood pressure and cardiovascular risk factors among HIV-positive individuals in rural Rakai District, Uganda. METHODS: We assessed 426 HIV-positive individuals in Rakai, Uganda from 2007 to 2010. Prevalence of hypertension and elevated blood pressure assessed by clinical measurement was compared to clinician-recorded hypertension in case report forms. Multiple logistic regression and z-tests were used to examine the association of hypertension and elevated blood pressure with age, sex, body mass index (BMI), CD4 cell count and antiretroviral treatment (ART) use. For individuals on antihypertensives, medication utilisation was reviewed. RESULTS: The prevalence of hypertension (two elevated blood pressure readings at different time points) was 8.0% (95% CI: 5.4-10.6%), and that of elevated blood pressure (one elevated blood pressure reading) was 26.3% (95% CI: 22.1-30.5%). Age ≥50 years and higher BMI were positively associated with elevated blood pressure. ART use, time on ART and CD4 cell count were not associated with hypertension. Eighty-three percent of subjects diagnosed with hypertension were on antihypertensive medications, most commonly beta-blockers and calcium channel blockers. CONCLUSIONS: Hypertension is common among HIV-positive individuals in rural Uganda.
OBJECTIVES: To assess the prevalence of hypertension, elevated blood pressure and cardiovascular risk factors among HIV-positive individuals in rural Rakai District, Uganda. METHODS: We assessed 426 HIV-positive individuals in Rakai, Uganda from 2007 to 2010. Prevalence of hypertension and elevated blood pressure assessed by clinical measurement was compared to clinician-recorded hypertension in case report forms. Multiple logistic regression and z-tests were used to examine the association of hypertension and elevated blood pressure with age, sex, body mass index (BMI), CD4 cell count and antiretroviral treatment (ART) use. For individuals on antihypertensives, medication utilisation was reviewed. RESULTS: The prevalence of hypertension (two elevated blood pressure readings at different time points) was 8.0% (95% CI: 5.4-10.6%), and that of elevated blood pressure (one elevated blood pressure reading) was 26.3% (95% CI: 22.1-30.5%). Age ≥50 years and higher BMI were positively associated with elevated blood pressure. ART use, time on ART and CD4 cell count were not associated with hypertension. Eighty-three percent of subjects diagnosed with hypertension were on antihypertensive medications, most commonly beta-blockers and calcium channel blockers. CONCLUSIONS:Hypertension is common among HIV-positive individuals in rural Uganda.
Authors: Gerald S Bloomfield; Prateeti Khazanie; Alison Morris; Cristina Rabadán-Diehl; Laura A Benjamin; David Murdoch; Virginia S Radcliff; Eric J Velazquez; Charles Hicks Journal: J Acquir Immune Defic Syndr Date: 2014-09-01 Impact factor: 3.731
Authors: Carlos Jericó; Hernando Knobel; Milagro Montero; María L Sorli; Ana Guelar; Juan L Gimeno; Pere Saballs; Jose L López-Colomés; Juan Pedro-Botet Journal: Am J Hypertens Date: 2005-11 Impact factor: 2.689
Authors: Thomas G Pickering; John E Hall; Lawrence J Appel; Bonita E Falkner; John Graves; Martha N Hill; Daniel W Jones; Theodore Kurtz; Sheldon G Sheps; Edward J Roccella Journal: Circulation Date: 2005-02-08 Impact factor: 29.690
Authors: Rhonda BeLue; Titilayo A Okoror; Juliet Iwelunmor; Kelly D Taylor; Arnold N Degboe; Charles Agyemang; Gbenga Ogedegbe Journal: Global Health Date: 2009-09-22 Impact factor: 4.185
Authors: J D Lundgren; M Battegay; G Behrens; S De Wit; G Guaraldi; C Katlama; E Martinez; D Nair; W G Powderly; P Reiss; J Sutinen; A Vigano Journal: HIV Med Date: 2008-02 Impact factor: 3.180
Authors: Anthony N Muiru; Prossy Bibangambah; Linda Hemphill; Ruth Sentongo; June-Ho Kim; Virginia A Triant; David R Bangsberg; Alexander C Tsai; Jeffrey N Martin; Jessica E Haberer; Yap Boum; Jorge Plutzky; Peter W Hunt; Samson Okello; Mark J Siedner Journal: J Acquir Immune Defic Syndr Date: 2018-08-01 Impact factor: 3.731
Authors: Martin Muddu; Andrew K Tusubira; Srish K Sharma; Ann R Akiteng; Isaac Ssinabulya; Jeremy I Schwartz Journal: J Acquir Immune Defic Syndr Date: 2019-08-15 Impact factor: 3.731
Authors: Ned Sacktor; Deanna Saylor; Gertrude Nakigozi; Noeline Nakasujja; Kevin Robertson; M Kate Grabowski; Alice Kisakye; James Batte; Richard Mayanja; Aggrey Anok; Ronald H Gray; Maria J Wawer Journal: J Acquir Immune Defic Syndr Date: 2019-06-01 Impact factor: 3.731
Authors: Robert Kalyesubula; Alex Kayongo; Fred Collins Semitala; Asaph Muhanguzi; Nehemiah Katantazi; Dieter Ayers; Jamie I Forrest; Edward J Mills Journal: BMJ Glob Health Date: 2016-11-24
Authors: Patrick Kazooba; Ivan Kasamba; Billy Nsubuga Mayanja; Joseph Lutaakome; Ivan Namakoola; Tino Salome; Pontiano Kaleebu; Paula Munderi Journal: Pan Afr Med J Date: 2017-05-15
Authors: Ahmed M Sarki; Chidozie U Nduka; Saverio Stranges; Ngianga-Bakwin Kandala; Olalekan A Uthman Journal: Medicine (Baltimore) Date: 2015-12 Impact factor: 1.817